{
  "main_header": {
    "sid": 1153953,
    "name": "EyePoint Pharmaceuticals, Inc.",
    "stock_name": "EyePoint Pharmaceuticals, Inc.",
    "full_name": "EyePoint Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/eyepoint-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "16.72",
    "chg": 3.03,
    "chgp": "22.13%",
    "dir": 1,
    "prev_price": "13.69",
    "mcapval": "940.86",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US30233G2093",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "4.06 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eyepoint-pharmaceuticals-inc-1153953-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "EyePoint Pharmaceuticals Hits New 52-Week High of $14.90",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eyepoint-pharmaceuticals-hits-new-52-week-high-of-1490-3586040",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/EyePointPharmac_priceRelatedfactors_3586040.png",
        "date": "2025-10-01 16:38:59",
        "description": "EyePoint Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting a strong performance over the past year. With a market capitalization of USD 941 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite facing financial challenges such as negative return on equity and a unique debt structure."
      },
      {
        "title": "Is EyePoint Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-eyepoint-pharmaceuticals-inc-technically-bullish-or-bearish-3546495",
        "imagepath": "",
        "date": "2025-09-20 19:34:14",
        "description": "As of 26 August 2025, the technical trend for EyePoint Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, supporting the positive stance. Daily moving averages also indicate a bullish trend. However, the monthly KST is bearish, which presents a mixed signal. The Dow Theory shows mildly bullish conditions on both weekly and monthly time frames. \n\nIn terms of performance, EyePoint has outperformed the S&P 500 across multiple periods, with a year-to-date return of 84.70% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish with moderate strength, driven primarily by the bullish MACD and Bollinger Bands...."
      }
    ],
    "total": 6,
    "sid": "1153953",
    "stock_news_url": "https://www.marketsmojo.com/news/eyepoint-pharmaceuticals-inc-1153953"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

EyePoint Pharmaceuticals Hits New 52-Week High of $14.90

2025-10-01 16:38:59

EyePoint Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting a strong performance over the past year. With a market capitalization of USD 941 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite facing financial challenges such as negative return on equity and a unique debt structure.

Read More

Is EyePoint Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:34:14

As of 26 August 2025, the technical trend for EyePoint Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, supporting the positive stance. Daily moving averages also indicate a bullish trend. However, the monthly KST is bearish, which presents a mixed signal. The Dow Theory shows mildly bullish conditions on both weekly and monthly time frames. In terms of performance, EyePoint has outperformed the S&P 500 across multiple periods, with a year-to-date return of 84.70% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish with moderate strength, driven primarily by the bullish MACD and Bollinger Bands....

Read More

View All News